ASPIRE Phase III trial of vaginal ring to prevent HIV completes enrollment of 2,629 women
ASPIRE, one of two Phase III trials of a promising method for preventing HIV in women – a vaginal ring worn for a month at a time – has completed enrollment of participants, with 2,629 women from 15 clinical research ...
Jun 26, 2014
0
0